Clinical Trial Search Results for "EXTRACT-TIMI 25"

Antman, E. M., Morrow, D. A., McCabe, C. H., Jiang, F., White, H. D., Fox, K. A., Sharma, D., Chew, P., Braunwald, E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) Am Heart J. 2005;149(2):217-26.

Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., Lopez-Sendon, J. L., Guneri, S., Jiang, F., White, H. D., Fox, K. A., Braunwald, E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med. 2006;354(14):1477-88.

Fox, K. A., Antman, E. M., Montalescot, G., Agewall, S., SomaRaju, B., Verheugt, F. W., Lopez-Sendon, J., Hod, H., Murphy, S. A., Braunwald, E. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2249-55.

Gibson, C. M., Murphy, S. A., Montalescot, G., Morrow, D. A., Ardissino, D., Cohen, M., Gulba, D. C., Kracoff, O. H., Lewis, B. S., Roguin, N., Antman, E. M., Braunwald, E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2238-46.

Giraldez, R. R., Nicolau, J. C., Corbalan, R., Gurfinkel, E. P., Juarez, U., Lopez-Sendon, J., Parkhomenko, A., Molhoek, P., Mohanavelu, S., Morrow, D. A., Antman, E. M. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis Eur Heart J. 2007;28(13):1566-73.

Mega, J. L., Morrow, D. A., Ostor, E., Dorobantu, M., Qin, J., Antman, E. M., Braunwald, E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction Circulation. 2007;115(22):2822-2828. Abstract

Morrow, D. A., Antman, E. M., Murphy, S. A., Qin, J., Ruda, M., Guneri, S., Jacob, A. J., Budaj, A., Braunwald, E. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial Am Heart J. 2007;154(6):1078-84, 1084 e1.

Ruff, C. T., Wiviott, S. D., Morrow, D. A., Mohanavelu, S., Murphy, S. A., Antman, E. M., Braunwald, E. TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction American Journal of Medicine. 2007;120(11):993-8. Abstract

Sabatine, M. S., Morrow, D. A., Dalby, A., Pfisterer, M., Duris, T., Lopez-Sendon, J., Murphy, S. A., Gao, R., Antman, E. M., Braunwald, E. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel J Am Coll Cardiol. 2007;49(23):2256-63.

Scirica, B. M., Morrow, D. A., Sadowski, Z., Ruda, M., Nicolau, J. C., Giugliano, R. P., Wiviott, S. D., Sabatine, M. S., Shui, A., Antman, E. M., Braunwald, E. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study Eur Heart J. 2007;28(17):2070-6.

Steinberg, B. A., Moghbeli, N., Buros, J., Ruda, M., Parkhomenko, A., Raju, B. S., Garcia-Castillo, A., Janion, M., Nicolau, J. C., Fox, K. A., Morrow, D. A., Gibson, C. M., Antman, E. M. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial Am Heart J. 2007;154(1):54-61.

White, H. D., Braunwald, E., Murphy, S. A., Jacob, A. J., Gotcheva, N., Polonetsky, L., Antman, E. M. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 Eur Heart J. 2007;28(9):1066-71.

Cheng, S., Morrow, D. A., Sloan, S., Antman, E. M., Sabatine, M. S. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction Circulation. 2009;119(9):1195-202.

Gibson, C. M., Pride, Y. B., Aylward, P. E., Col, J. J., Goodman, S. G., Gulba, D., Bergovec, M., Kunadian, V., Zorkun, C., Buros, J. L., Murphy, S. A., Antman, E. M. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis J Thromb Thrombolysis. 2009;27(1):7-Nov.

Giraldez, R. R., Sabatine, M. S., Morrow, D. A., Mohanavelu, S., McCabe, C. H., Antman, E. M., Braunwald, E. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction American heart journal. 2009;157(3):517-24. Abstract

Giraldez, R. R., Wiviott, S. D., Nicolau, J. C., Mohanavelu, S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis Drugs. 2009;69(11):1433-43. Abstract

Thomas, D., Giugliano, R. P. ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy J Thromb Thrombolysis. 2009;27(1):10-Jan. Abstract

Giugliano, R. P., Giraldez, R. R., Morrow, D. A., Antman, E. M., Gibson, C. M., Mohanavelu, S., Murphy, S. A., McCabe, C. H., Braunwald, E. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial Eur Heart J. 2010;31(17):2103-10. Abstract

Morrow, D. A., Antman, E. M., Fox, K. A., White, H. D., Giugliano, R., Murphy, S. A., McCabe, C. H., Braunwald, E. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial European heart journal. 2010;31(17):2097-102. Abstract

Mogabgab, O., Giugliano, R. P., Sabatine, M. S., Cannon, C. P., Mohanavelu, S., Wiviott, S. D., Antman, E. M., Braunwald, E. Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction Chronobiology International. 2012;29(10):1390-1396. Abstract

Amin, S. T., Morrow, D. A., Braunwald, E., Sloan, S., Contant, C., Murphy, S., Antman, E. M. Dynamic TIMI Risk Score for STEMI J Am Heart Assoc. 2013;2(1):e003269. Abstract